Lam Research LRCX
US equityMarket cap rank #66Semiconductor Equipment & MaterialsSemiconductorsArtificial Intelligence
$200.44 +$15.24 (+8.23%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $201.17 +0.36%
Open$208.65
Prev close$185.20
Day range$198.07 – $209.20
Volume17.96M
Market cap$250.38B
P/E (TTM)29.9
Dividend yield0.55%
Fundamentals
Latest reported quarter: Q1, ended Sep 2026
Revenue$8.22B+54.4% YoY
Operating profit$3.28B+79.5% YoY
Net profit$2.75B+75.5% YoY
Diluted EPS$2.19+76.6% YoY
Free cash flow$3.24B+103.3% YoY
Operating cash flow$3.50B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin51.1%
Operating margin37.0%
Net margin32.3%
Return on equity70.1%
Return on assets35.0%
Return on invested capital52.1%
Current ratio2.48
Liabilities / assets47.2%
Cash & investments$7.44B
Total debt$3.74B
Net cash (debt)$3.70B
Free cash flow / sales25.0%
Income statement
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $8.22B | $23.23B | $6.72B | $5.84B | $5.34B |
| Total Operating Revenue | $8.22B | $23.23B | $6.72B | $5.84B | $5.34B |
| Cost of Revenue | $3.92B | $11.51B | $3.24B | $2.93B | $2.69B |
| Gross Profit | $4.30B | $11.73B | $3.48B | $2.91B | $2.65B |
| Operating Expense | $1.02B | $3.53B | $965.25M | $863.51M | $840.96M |
| Selling and Admin Expenses | $348.73M | $1.15B | $322.33M | $280.31M | $267.65M |
| Research & Development | $666.40M | $2.38B | $642.92M | $583.20M | $573.31M |
| Operating Profit | $3.28B | $8.20B | $2.51B | $2.05B | $1.81B |
| Net Non-Operating Interest Income (Expense) | $13.09M | $39.31M | $2.26M | $3.31M | $12.28M |
| Non-Operating Interest Income | $49.85M | $196.19M | $36.47M | $42.64M | $53.16M |
| Non-Operating Interest Expense | $36.76M | $156.88M | $34.20M | $39.33M | $40.88M |
| Other Income (Expense) | $15.41M | $23.37M | $39.39M | -$38.77M | $14.13M |
| Gain on Sale of Security | $3.89M | -$30.08M | -$15.46M | -$1.05M | -$8.03M |
| Other Non-Operating Income (Expenses) | $11.52M | $53.46M | $54.86M | -$37.72M | $22.17M |
| Pretax Profit | $3.31B | $8.26B | $2.56B | $2.01B | $1.84B |
| Tax | $559.08M | $997.08M | $277.86M | $186.10M | $242.62M |
| Net Profit | $2.75B | $7.27B | $2.28B | $1.83B | $1.59B |
| Profit from Continuing Operations | $2.75B | $7.27B | $2.28B | $1.83B | $1.59B |
| Net Income to Parent Company | $2.75B | $7.27B | $2.28B | $1.83B | $1.59B |
| Net Income to Common Stockholders | $2.75B | $7.27B | $2.28B | $1.83B | $1.59B |
| Basic EPS | $2.20 | $5.79 | $1.82 | $1.46 | $1.27 |
| Diluted EPS | $2.19 | $5.76 | $1.81 | $1.45 | $1.26 |
| Dividend Per Share | $0.33 | $1.04 | $0.26 | $0.26 | $0.26 |
| Special Income (Charges) | – | $0.00 | – | – | – |
| -Less:Restructuring and Mergern & Acquisition | – | $0.00 | – | – | – |
Balance sheet
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Total Assets | $26.35B | $23.53B | $23.53B | $20.79B | $21.39B |
| Total Current Assets | $18.12B | $15.61B | $15.61B | $13.30B | $14.02B |
| Cash and Cash Equivalents & Short-Term Investments | $7.44B | $5.58B | $5.58B | $4.75B | $6.18B |
| -Cash and Cash Equivalents | $7.44B | $5.58B | $5.58B | $4.75B | $6.18B |
| Receivables | $5.66B | $5.34B | $5.34B | $4.13B | $3.49B |
| -Accounts Receivable | $5.66B | $5.34B | $5.34B | $4.13B | $3.49B |
| Inventory | $4.55B | $4.28B | $4.28B | $4.00B | $4.04B |
| Other Current Assets | $477.81M | $415.74M | $415.74M | $413.10M | $307.91M |
| Total Non-Current Assets | $8.23B | $7.92B | $7.92B | $7.49B | $7.37B |
| Net PPE | $3.13B | $2.96B | $2.96B | $2.85B | $2.71B |
| -Gross PPE | $5.71B | $5.44B | $5.44B | $5.25B | – |
| -Accumulated Depreciation | -$2.58B | -$2.48B | -$2.48B | -$2.40B | – |
| Goodwill and Other Intangible Assets | $1.91B | $1.90B | $1.90B | $1.88B | $1.86B |
| Other Non-Current Assets | $3.19B | $3.07B | $3.07B | $2.76B | $2.80B |
| Total Liabilities | $12.44B | $11.06B | $11.06B | $10.21B | $11.25B |
| Total Current Liabilities | $7.31B | $5.94B | $5.94B | $5.24B | $6.21B |
| Payables | $2.81B | $1.89B | $1.89B | $1.59B | $1.57B |
| -Accounts Payable | $1.59B | $1.30B | $1.30B | $1.07B | $1.03B |
| -Total Tax Payable | $800.78M | $263.21M | $263.21M | $188.60M | $218.63M |
| -Dividends Payable | $412.22M | $325.40M | $325.40M | $325.32M | $325.83M |
| Short-Term Debt and Capital Lease Obligation | $3.49M | $4.07M | $4.07M | $4.10M | $754.01M |
| -Current Debt | $3.49M | $147,000.00 | $147,000.00 | $4.10M | $754.01M |
| Current Provisions | $320.69M | $270.04M | $270.04M | $241.53M | $234.49M |
| Current Deferred Liabilities | $2.43B | $2.28B | $2.28B | $2.09B | $2.16B |
| Other Current Liabilities | $886.34M | $797.39M | $797.39M | $719.71M | $690.61M |
| Total Non-Current Liabilities | $5.13B | $5.12B | $5.12B | $4.96B | $5.03B |
| Long Term Accounts Payable and Other Payables | $684.27M | $681.20M | $681.20M | $621.57M | $667.64M |
| Long Term Debt and Capital Lease Obligation | $3.73B | $3.73B | $3.73B | $3.73B | $3.73B |
| -Long Term Debt | $3.73B | $3.72B | $3.72B | $3.73B | $3.73B |
| Other Non-Current Liabilities | $715.85M | $709.89M | $709.89M | $612.78M | $635.21M |
| Total Equity | $13.91B | $12.47B | $12.47B | $10.58B | $10.15B |
| Stockholders' Equity | $13.91B | $12.47B | $12.47B | $10.58B | $10.15B |
| Capital Stock | $1.25M | $1.25M | $1.25M | $1.25M | $1.25M |
| -Common Stock | $1.25M | $1.25M | $1.25M | $1.25M | $1.25M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $9.36B | $9.24B | $9.24B | $9.05B | $8.95B |
| Retained Earnings | $37.29B | $34.95B | $34.95B | $33.00B | $31.50B |
| Less: Treasury Stock | $32.62B | $31.60B | $31.60B | $31.35B | $30.20B |
| Gains/Losses Not Affecting Retained Earnings | -$127.29M | -$127.09M | -$127.09M | -$121.39M | -$98.70M |
| -Current Capital Lease Obligation | – | $3.93M | $3.93M | – | – |
| -Long Term Capital Lease Obligation | – | $8.58M | $8.58M | – | – |
Cash flow
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3.50B | $5.86B | $1.46B | $1.14B | $1.48B |
| Net cash flow from continuing operations | $3.50B | $5.86B | $1.46B | $1.14B | $1.48B |
| Net Income from Continuing Operations | $2.75B | $7.27B | $2.28B | $1.83B | $1.59B |
| Depreciation & Depletion & Amortization | $122.07M | $441.53M | $119.64M | $116.32M | $103.93M |
| Deferred Tax | -$55.30M | -$289.06M | -$175.75M | -$19.48M | -$30.96M |
| Other Non-Cash Items | $27.63M | -$32.71M | -$8.01M | -$2.86M | -$19.96M |
| Change in Working Capital | $535.41M | -$1.91B | -$859.92M | -$874.65M | -$255.50M |
| Net cash flow from investing | -$266.99M | -$922.15M | -$143.74M | -$334.58M | -$257.78M |
| Net Cash Flow from Continuing Investing Activities | -$266.99M | -$922.15M | -$143.74M | -$334.58M | -$257.78M |
| Capital Expenditure | -$257.70M | -$966.41M | -$188.80M | -$331.60M | -$260.88M |
| Net Other Investing Changes | -$9.29M | $44.25M | $45.06M | -$2.98M | $3.10M |
| Financing Cash Flow | -$1.38B | -$5.72B | -$480.31M | -$2.23B | -$1.73B |
| Net Cash Flow from Continuing Financing Activities | -$1.38B | -$5.72B | -$480.31M | -$2.23B | -$1.73B |
| Net Issuance Payments Of Debt | -$34.49M | -$755.43M | -$1.36M | -$751.19M | -$1.46M |
| Net Common Stock Issuance | -$1.02B | -$3.83B | -$242.13M | -$1.15B | -$1.46B |
| Cash Dividends Paid | -$325.40M | -$1.27B | -$325.32M | -$325.83M | -$327.51M |
| Net Other Financing Charges | -$1.79M | -$13.79M | -$282,000.00 | $55,000.00 | -$1.12M |
| Ending Cash Balance | $7.45B | $5.60B | $5.60B | $4.77B | $6.20B |
| Net Change in Cash | $1.85B | -$782.28M | $833.18M | -$1.42B | -$502.94M |
| Beginning Cash Balance | $5.60B | $6.41B | $4.77B | $6.20B | $6.71B |
| Effect of Exchange Rate Changes | $4.66M | -$27.43M | -$2.06M | -$4.98M | -$13.34M |
| Free Cash Flow | $3.24B | $4.89B | $1.27B | $809.82M | $1.22B |
| -Change in Receivables | – | -$1.96B | – | – | – |
| -Change in Inventory | – | -$93.86M | – | – | – |
| -Change in Prepaid Assets | – | $50.24M | – | – | – |
| -Change in Payables and Accrued Expense | – | $378.22M | – | – | – |
| -Change In Other Working Capital | – | -$286.37M | – | – | – |
| Net Investment Purchase and Sale | – | $0.00 | – | – | – |
| Proceeds from Stock Option Exercised | – | $155.97M | $88.78M | $0.00 | – |
No comments yet — be the first to weigh in on LRCX.
Sign in to join the discussion.